# Slate Pharmaceuticals, Inc.: Form D filings

Slate Pharmaceuticals, Inc., a pharmaceuticals company in Durham, NC, filed 4 Form D notices with the SEC between 2009 and 2010. The latest, on September 27, 2010, reports $2 million sold of a $2 million offering to 40 investors.

Find out what Slate Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Slate%20Pharmaceuticals%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Slate%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fslate-pharmaceuticals-inc-1469231)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Slate%20Pharmaceuticals%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Slate%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fslate-pharmaceuticals-inc-1469231)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina): 984 rows, by operating companies, filed since November 1, 2024, $49.20, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/north-carolina
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 318 BLACKWELL STREET, SUITE 240, Durham, NC, 27701
- Phone: (919) 682-8800
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2007
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1469231

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sep 27, 2010 | New notice | $2,000,000 | $1,990,000 | $10,000 | 40 | Sep 13, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469231/000146923110000002/0001469231-10-000002-index.htm) |
| Jan 29, 2010 | Amendment | $2,787,000 | $2,787,000 | $0 | 33 | Aug 7, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469231/000146923110000001/0001469231-10-000001-index.htm) |
| Nov 19, 2009 | Amendment | $2,787,000 | $2,616,950 | $170,050 | 33 | Aug 7, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469231/000146923109000002/0001469231-09-000002-index.htm) |
| Aug 18, 2009 | New notice | $2,787,000 | $970,630 | $1,816,370 | 13 | Aug 7, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1469231/000146923109000001/0001469231-09-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Robert Stanley Whitehead | Executive Officer, Director |  |
| Douglas Stanley Eckert | Director |  |
| Michael Stanley Ford | Director |  |
| Richard Robert DeSchutter | Director |  |
| Anthony Robert Wild | Director |  |
| William Robert Dahl | Director |  |
| Trygve Robert Mikkelsen | Director |  |

## Other pharmaceuticals companies in North Carolina that filed recently

- [Dignify Therapeutics, LLC](https://specstream.ai/data/form-d/company/dignify-therapeutics-llc-1622906) $800,000 · Sep 25, 2026

[Every Form D from the week of Sep 27, 2010](https://specstream.ai/data/form-d/week/2010-09-27) · [All recent filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Slate Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).